Research article · 15 May 2026
Review articlePublished 2017
Advances in ALK Targeted Therapy for Neuroblastoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Significant advances have been made to understand the association between ALK genetic aberrations and disease prognosis in neuroblastoma. ALK targeted therapies are evolving quickly and several randomized controlled trials of ALK inhibitors are underway or nearing completion in adult cancers. Ongoing research will bring new challenges and newer technologies to fully define the pathogenic and prognostic alterations, to stratify the risk of recurrence or progression, and to develop optimal monitoring and treatment strategies in this malignancy.
Keywords
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Oncology Translational Research.
Research article · 15 Dec 2025
Cardiac Substructure Analysis of Radiation-associated Cardiac Disease in Thoracic Malignancy Patients
Brief report · 29 Nov 2025
CDx: Navigating Global Regulations for Precision Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Oncology Translational Research
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Libo Zhang”
- BylineArticles whose byline prints “Sylvain Baruchel”
